Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis

Condition:   Primary Biliary CirrhosisInterventions:   Biological: NGM282;   Biological: PlaceboSponsors:   NGM Biopharmaceuticals, Inc;   NGM Biopharmaceuticals Australia Pty LtdRecruiting - verified March 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials